Table 2.
Protein deleted | Resulting β-cell function | Insulin action | Effect on glycemic control |
---|---|---|---|
Irs1 | Increased β-cell mass | Mild defects | Normal |
Irs2 | Decreased β-cell mass | Impaired insulin action | Frank diabetes |
Akt-2 | Normal | Impaired signaling | Hyperglycemia |
Slc2a4 | Normal | Moderate insulin resistance | Hyperglycemia (in males) |
Muscle-specific Slc2a4 | Normal | Very insulin-resistant | Impaired glucose tolerance; diabetes in a subset |
Fat-specific Slc2a4 | Normal | Reduced suppression of gluconeogenesis | Impaired glucose tolerance; diabetes in a subset |
Abbreviations: Akt-2, RAC-β serine/threonine-protein kinase; Irs, insulin receptor substrate; Slc2a4, solute carrier family 2, member 4 (previously termed Glut4).